D055293Chemicals & DrugsD12.776.543.750.887D23.050.301.264.035.911D23.101.100.110.917570.990027Receptors, Urokinase Plasminogen ActivatorFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryCancer BiologyWake Forest School of MedicineDonaldBowdenDonald W. Bowden PhD36.09040200000000-80.26700599999999192Bowden, DonaldProfessorJohnMcConnellJohn D. McConnell MD36.09003100000000-80.26802800000000405McConnell, JohnProfessorBarryFreedmanBarry I. Freedman MD36.08959100000000-80.2685990000000078Freedman, BarryProfessorBayardPowellBayard L. Powell MD36.08919100000000-80.2667780000000099Powell, BayardProfessor26539740Skorecki KL, Freedman BIThe New England journal of medicineSkorecki KL, Freedman BI. A suPAR Biomarker for Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1971-2.N Engl J Med2015-11-05T00:00:002015A suPAR Biomarker for Chronic Kidney Disease.NeveenSaidNeveen Said MD, PhD36.09032400000000-80.266491000000001834Said, NeveenAssociate Professor22577342Al-Hassan NN, Behzadian A, Caldwell R, Ivanova VS, Syed V, Motamed K, Said NANeoplasia (New York, N.Y.)Al-Hassan NN, Behzadian A, Caldwell R, Ivanova VS, Syed V, Motamed K, Said NA. Differential roles of uPAR in peritoneal ovarian carcinomatosis. Neoplasia. 2012 Apr; 14(4):259-70.Neoplasia2012-04-01T00:00:002012Differential roles of uPAR in peritoneal ovarian carcinomatosis.28650456Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser JNature medicineHayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J. A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.Nat Med2017-06-26T00:00:002017A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease.29716888Hayek SS, Divers J, Raad M, Xu J, Bowden DW, Tracy M, Reiser J, Freedman BIJournal of the American Heart AssociationHayek SS, Divers J, Raad M, Xu J, Bowden DW, Tracy M, Reiser J, Freedman BI. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein. J Am Heart Assoc. 2018 05 01; 7(9).J Am Heart Assoc2018-05-01T00:00:002018Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.22Associate ProfessorInternal Medicine, Hematology & OncologyInternal Medicine, NephrologyUrologytrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor21998707Liu G, Yang Y, Yang S, Banerjee S, De Freitas A, Friggeri A, Davis KI, Abraham EPloS oneLiu G, Yang Y, Yang S, Banerjee S, De Freitas A, Friggeri A, Davis KI, Abraham E. The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils. PLoS One. 2011; 6(10):e25843.PLoS One2011-10-05T00:00:002011The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils.1.372880.01410895research area of0.6674990.057004311subject area for